PGEN
Precigen, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.10
−0.56%Forward multiples
Based on analyst estimates
- P/E forward
- 14.64x
- P/E 2026E
- 50.96x
- P/E 2027E
- 10.44x
- P/E 2028E
- 11.60x
- P/S forward
- 8.02x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 58.34x
- Price / sales
- 29.66x
- Price / cash flow
- -22.27x
Enterprise value
- Enterprise value
- $2.6B
- EV / sales
- 30.36x
- EV / EBITDA
- -17.95x
- EV / EBIT
- -65.88x
- Market cap
- $2.5B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026